Skip to main content
. 2021 May 26;37(3):548–557. doi: 10.1007/s00455-021-10305-4

Table 3.

Case series patient demographics and swallowing dysfunction

Case no Gender Age Type of sarcoid Endoscopic surgical interventions SLT intervention FOIS pre-op FOIS post-op Pre-op VFS Pre-op FEES Post-op VFS Post-op FEES
1 F 56 Systemic—nasal and laryngeal  × 2 Food textures, voice and reflux advice 7 6 Incomplete epiglottic deflection, reduced laryngeal elevation, penetration and aspiration during the swallow. PAS 6 No No Scarred and stiff epiglottis, reduced adduction of vocal cords, reduced tongue base retraction and epiglottic deflection, spontaneous clearance of penetration. PAS 2, RS 1
2 M 45 Systemic—nasal, laryngeal and suspected neuro  × 2 Assessment only 7 No No Variable swallow trigger. PAS 1 No
3 F 35 Laryngeal  × 3 Safe eating strategies 5 No Reduced tongue base retraction and pharyngeal squeeze, penetration during and post-swallow. PAS 3, RS 2 No No
4 F 34 Systemic—pulmonary and laryngeal  × 3 Safe eating strategies, chronic cough and hypersensitivity therapy including reflux management 5 No Very bulky arytenoids with minimal pyriform space. Hypersensitivity. Penetration and aspiration during and post-swallow. PAS 8, RS 0 No No
5 F 54 Systemic—pulmonary, nasal and laryngeal  × 1 No swallow therapy as patient wished to focus on voice therapy only 6 5 No No No Delayed swallow trigger, reduced pharyngeal squeeze, penetration during swallow PAS 5, RS 1
6 M 22 Laryngeal  × 1 Pre-op advice. Post-op swallow therapy exercises – Effortful and Masako 7 7 No Delayed swallow trigger, nil epiglottic deflection, reduced pharyngeal squeeze, penetration and aspiration during swallow. PAS 8, RS 1 No Less oedema of supraglottic structures, nil epiglottic deflection, penetration during and post-swallow. PAS 5, RS 2
7 F 70 Systemic—pulmonary and laryngeal 0*

2 × periods of voice and swallow therapy

2016—Masako, Shaker and Effortful swallow exercises

2018—6 weeks of further swallow therapy

5 No No Delayed swallow trigger, significantly reduced pharyngeal squeeze, reduced hyolaryngeal excursion and reduced cricopharyngeal opening, with diffuse residue, penetration during swallow. PAS 4 No

PAS Penetration-Aspiration Scale, RS Residue Score

*Patient had multiple in-office vocal cord augmentation injections but no dilatation